In development for UK general practice
Clinical intelligence. Connected to the work that matters.
Reedley is being built to read letters, results and prescription requests against the patient record, prepare the work each implies with its evidence, and leave every decision with clinicians.
In development · every demonstration uses synthetic data
Margaret ASHWORTH NHS 999 000 0107
Born 14 May 1947 · 79 y · Female
Step 1 of 4 · A letter arrives · Continues as you scroll
- A letter arrives
- Medication changes found
- Compared with the record
- Awaiting a clinician
Step 1 · A letter arrives
Cardiology clinic letter · Northfield General Hospital (fictional)
- Dated 14 Sep 2026 · received 2 Oct 2026 15:40 via MESH (simulated)
- Identity matched to the record: name, date of birth, NHS number
“Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107”
Identifiedreceived is not reviewed
Step 2 · Medication changes found
Northfield General Hospital (fictional)
Blood pressure remains above target. I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily. Continue apixaban 5 mg twice daily.
Step 3 · Compared with the record
| Medicine | Letter | Record | Result |
|---|---|---|---|
| Ramipril | 10 mg once daily | 5 mg once daily | Letter and record differ |
| Bisoprolol | 5 mg once daily | 2.5 mg once daily | Letter and record differ |
| Apixaban | 5 mg twice daily (continue) | 5 mg twice daily | Letter and record match |
Sources: Cardiology clinic letter ¶2 · dated 14 Sep 2026; medication record · as at 5 Oct 2026
Step 4 · Awaiting a clinician
Identified3 proposals · awaiting review by a clinician
- Medication record differs from the letter: ramipril, bisoprololPrescriber review requiredCardiology clinic letter ¶2 · dated 14 Sep 2026
- U&E within 2 weeks of the dose change · overdue by 7 daysDraft rule · clinical reviewCardiology clinic letter ¶3 · dated 14 Sep 2026 · Practice monitoring rule · draft · unsigned
- ramipril: prescriber review before reauthorisationPrescriber review requiredrepeat authorisation · as at 5 Oct 2026
Rests here. Nothing is accepted, assigned or changed until a named clinician reviews the evidence.
As of 5 Oct 2026 08:03. Reedley does not change the medication record. Every person and organisation shown is fictional.
In the development build · synthetic data · Scripted reconstruction: the development build itself is not running on this page.
Step 1 of 3 · A letter arrives · Continues as you scroll
- A letter arrives
- Compared with the record
- Awaiting a clinician
Step 1 · A letter arrives
Cardiology clinic letter · Northfield General Hospital (fictional)
- Dated 14 Sep 2026 · received 2 Oct 2026 15:40 via MESH (simulated)
- Identity matched to the record: name, date of birth, NHS number
“Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107”
Identifiedreceived is not reviewed
Step 2 · Compared with the record
| Medicine | Letter | Record | Result |
|---|---|---|---|
| RamiprilMedication change · ramipril 5 mg → 10 mg once daily · ¶2 | 10 mg once daily | 5 mg once daily | Letter and record differ |
| BisoprololMedication change · bisoprolol 2.5 mg → 5 mg once daily · ¶2 | 5 mg once daily | 2.5 mg once daily | Letter and record differ |
| ApixabanInformation · apixaban: continue · ¶2 | 5 mg twice daily (continue) | 5 mg twice daily | Letter and record match |
Sources: Cardiology clinic letter ¶2 · dated 14 Sep 2026; medication record · as at 5 Oct 2026
Step 3 · Awaiting a clinician
Identified3 proposals · awaiting review by a clinician
- Medication record differs from the letter: ramipril, bisoprololPrescriber review requiredCardiology clinic letter ¶2 · dated 14 Sep 2026
- U&E within 2 weeks of the dose change · overdue by 7 daysDraft rule · clinical reviewCardiology clinic letter ¶3 · dated 14 Sep 2026 · Practice monitoring rule · draft · unsigned
- ramipril: prescriber review before reauthorisationPrescriber review requiredrepeat authorisation · as at 5 Oct 2026
Rests here. Nothing is accepted, assigned or changed until a named clinician reviews the evidence.
As of 5 Oct 2026 08:03. Reedley does not change the medication record. Every person and organisation shown is fictional.
In the development build · synthetic data · Scripted reconstruction: the development build itself is not running on this page.
The work today
Primary care work arrives in pieces.
A specialist letter, a medication list, an overdue blood test and a repeat request sit in different windows, and someone has to join them up.
Margaret ASHWORTH NHS 999 000 0107
Born 14 May 1947 · 79 y · Female
Step 1 of 4 · Five places, one patient · Illustrative · Continues as you scroll
- Five places, one patient Illustrative
- Brought into one workspace
- Connected clinical context
- Reviewable actions
Margaret ASHWORTH — after the cardiology letter of 14 Sep (received 2 Oct)
Specialist letter
- Cardiology clinic letter · dated 14 Sep 2026 · received Fri 2 Oct 15:40
“I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily.”
Source Cardiology clinic letter ¶2 · dated 14 Sep 2026
Medication list
- Ramipril 5 mg once daily
- Bisoprolol 2.5 mg once daily
- Apixaban 5 mg twice daily
- Atorvastatin 40 mg at night
- Amlodipine 5 mg once daily
- Metformin 500 mg twice daily
Source medication record · as at 5 Oct 2026
Pending review
- Ramipril 5 mg capsules · 0 issues remaining · reauthorisation needs a prescriber
Source repeat authorisation · as at 5 Oct 2026
Missing monitoring result
- Latest U&E 4 Sep 2026: potassium 4.8 mmol/L, eGFR 44 · no laboratory flag
- Letter dated 14 Sep asks for U&E within 2 weeks of the dose change: no result on the record since 4 Sep
Source Result · 4 Sep 2026 · Cardiology clinic letter ¶3 · dated 14 Sep 2026
Prescription request
- Paper slip · received Fri 2 Oct 16:10
- Bisoprolol 2.5 mg tablets, one daily
Source Prescription request · received 2 Oct 2026 16:10
“Dizziness on standing since the hospital increased her blood pressure tablets. BP 108/62.”
Consultation · 28 Sep 2026 · Dr S. PATEL
one clinical review · 3 items, each with its own state
- Medication record differs from the letter: ramipril, bisoprololIdentifiedFor a prescriber
- U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysIdentifiedFor clinical review · draft rule
- ramipril: prescriber review before reauthorisationIdentifiedFor a prescriber
Linked request: bisoprolol 2.5 mg (paper)
The request’s dose differs from the letter’s 5 mg; it is shown beside the letter, not decided.
Synthetic data · scripted demonstration. Each step carries its own label: In the development build · synthetic data, or Illustrative demonstration · intended workflow. Every person and organisation shown is fictional.
In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.
Fragments in. Context assembled. Actions reviewable.
Reedley is being built to gather what arrives, set it against the record and turn it into proposed actions a clinician can check against the evidence.
Fragmented information
One letter, one medication list, one pending authorisation, one missing result and one request, in five places.
Illustrative demonstration · intended workflowConnected clinical context
The same five things for one patient, side by side, each linked to its source.
In the development build · synthetic dataReviewable actions
Three proposals, each cited, waiting for a named clinician to accept, edit or reject.
In the development build · synthetic data
Capabilities
What Reedley prepares for you.
Six workflows, from documents and reconciliation to questions, medication review, shortages and complex letters, each shown with its current status.
- In the development build · synthetic data
Document Intelligence
Letters read with you, every finding linked to evidence.
See the capability - Illustrative demonstration · intended workflow
Medication Reconciliation
Letter against record, differences ready for review.
See the capability - In the development build · synthetic data
Ask Reedley
Questions about one patient, answered with their sources.
See the capability - Illustrative demonstration · intended workflow
Reedley Review
Medicines, results and letters assembled for a review.
See the capability - Illustrative demonstration · intended workflow
Medicines Shortages
The patient and product factors a prescriber weighs.
See the capability - Illustrative demonstration · intended workflow
Complex Medication Changes
Specialist letters structured into instructions, questions and plans.
See the capability
The complete workflow
One letter, followed all the way through.
A document enters, context is assembled, changes are identified, the clinician reviews the evidence, a handover is prepared and the trail remains.
- What entersA cardiology clinic letter for one synthetic patient.
- What Reedley preparesContext, findings and proposals, each with its source; an illustrative handover draft.
- What stays with the clinicianEvery decision. Nothing is sent, and the medication record is not changed.
One cardiology letter followed from arrival to handover. Every person and organisation shown is fictional; the times are the synthetic record’s own, and the demonstration compresses them.
Margaret ASHWORTH NHS 999 000 0107
Born 14 May 1947 · 79 y · Female
One cardiology letter followed from arrival to handover. Every person and organisation shown is fictional; the times are the synthetic record’s own, and the demonstration compresses them.
Step 1 of 6 · A document enters · Continues as you scroll
- A document enters
- Context assembled
- Changes and actions found
- Clinician reviews evidence
- Handover prepared Illustrative
- Work stays traceable
Step 1 · A document enters
Cardiology clinic letter received via MESH (simulated). Identity matched to the record. Received is not reviewed.
Received 2 Oct 2026 15:40 via MESH (simulated)
Patient: Margaret ASHWORTH · born 14 May 1947 · NHS 999 000 0107
Identifieddocument review
Step 2 · Context assembled
Record, results, the 28 Sep consultation and the paper request, beside the letter.
As at 5 Oct 2026
Ramipril 5mg capsules · 5 mg once daily
Northfield Pathology (fictional)
Potassium 4.8 mmol/L · eGFR 44 mL/min/1.73m² · no laboratory flag
Dr S. PATEL
Dizziness on standing since the hospital increased her blood pressure tablets. BP 108/62. Advised to monitor; awaiting clinic letter.
Received 2 Oct 2026 16:10
Repeat request (paper slip): bisoprolol 2.5 mg tablets, one daily.
Identifieddocument review
Step 3 · Changes and actions found
Two dose changes that differ from the record, a U&E request and a reauthorisation decision, each cited to ¶2 or ¶3.
Northfield General Hospital (fictional)
Blood pressure remains above target. I have increased ramipril from 5 mg to 10 mg once daily and increased bisoprolol from 2.5 mg to 5 mg once daily. Continue apixaban 5 mg twice daily.
Northfield General Hospital (fictional)
Please check urea and electrolytes within 2 weeks of the dose change. Echocardiogram arranged; review in 3 months.
- Medication record differs from the letter: ramipril, bisoprololDraft · not reviewed
- U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysDraft · not reviewed
- ramipril: prescriber review before reauthorisationDraft · not reviewed
Identifiedproposals
Step 4 · Clinician reviews evidence
K. AHMED reviews the letter with the record beside it and accepts the proposals. Three work items are created.
Document reviewReviewed by K. AHMED · 08:29
- Medication record differs from the letter: ramipril, bisoprololIdentifiedthis item
- U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysIdentified
- ramipril: prescriber review before reauthorisationIdentified
Step 5 · Handover prepared Illustrative
Assigned to Dr S. PATEL, due 6 Oct, with a handover note to copy into the practice’s own message.
Copy-out only; nothing is written to any record. Copied text starts “DRAFT · SYNTHETIC DEMONSTRATION · NOT FOR CLINICAL USE”.
Copy-out only; Reedley sends nothing.
Step 6 · Work stays traceable
Every event is kept with who, when and the evidence. The item rests at assigned.
Medication record differs from the letter: ramipril, bisoprololDr S. PATEL, GP · due 6 Oct
- Identified5 Oct 08:29
- Reviewed5 Oct 08:36
- Assigned5 Oct 08:36
- Actionednot yet
- Verifiednot yet
- Closednot yet
Not verified: the medication record still shows ramipril 5 mg and bisoprolol 2.5 mg. Intended: verified when the record, re-read, shows the prescriber’s recorded decision (simulated here). A person’s report moves an item to actioned; verification comes from the record where Reedley can read it; where it cannot, a named person’s structured statement is accepted today, and that rule is under review.
- U&E within 2 weeks of the dose change (ramipril) · overdue by 7 daysAssignedK. AHMED · due 7 Oct
- ramipril: prescriber review before reauthorisationAssignedDr S. PATEL, GP · due 9 Oct
Event historyAppend-only by design · who, when, what
- · ReedleyLetter received; identity verified; document review identified.
- · ReedleyReview prepared: findings cited to ¶2 and ¶3; three proposals.
- · K. AHMEDLetter reviewed; proposals accepted; this item identified.
- · K. AHMEDItem reviewed and assigned to Dr S. PATEL, due 6 Oct; handover note prepared.
Synthetic data · scripted demonstration. Each step carries its own label: In the development build · synthetic data, or Illustrative demonstration · intended workflow. Source checks are simulated; Reedley does not change the medication record.
In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.
Demonstrations
See Reedley in action.
Three flagship demonstrations on synthetic patients. Play, pause and step through each one here, then open it in full on its own page.
Ask Reedley
In the development build · synthetic data- Arrives
- A question about one patient
- Reedley prepares
- An answer line by line, each line linked to its source
- The clinician decides
- You judge the answer against the sources
Step 1 of 4 · Question asked · Continues as you scroll
- Question asked
- Searching the record
- Findings with sources
- More questions Illustrative
When was the latest renal function result recorded?
62 entries supplied for this synthetic patient
- Consultations8: not needed for this question.
- Letter paragraphs (3 letters)11: not needed for this question.
- Results7: read for this question, 3 cited in the answer.
- Medication history8: not needed for this question.
- Current medication record5: not needed for this question.
- Referrals2: not needed for this question.
- Problems4: not needed for this question.
- Allergies and intolerances1: not needed for this question.
- Reedley work history16: read for this question, 1 cited in the answer.
Counts are the entries supplied to this demonstration. Reedley cannot see anything that was not supplied.
- ResultsFound · 3 sources
- Reedley work historyFound · 1 source
One answer, each line linked to the entries it rests on
The latest U&E was received in the record on 9 Nov 2026 at 15:20 (sample taken 9 Nov 08:50). As reported: creatinine 131 µmol/L, eGFR 52 mL/min/1.73m², no laboratory flag.
- Record factShown as the laboratory reported it (Northfield Pathology, fictional).E1Result · received 9 Nov 2026 15:20
- Record factA clinician’s review of this result is recorded.E2Reedley work history · 12 Nov 2026 08:31
- Record factEarlier U&E results, listed as reported for context: 3 Jun 2026 and 14 Nov 2025.E3Result · received 3 Jun 2026 15:48E4Result · received 14 Nov 2025 16:05
Uncertainty Shows when results arrived in the record and what the laboratory reported. Reedley does not interpret results or the change between them.
What was searched · 2 sources, 23 entries read, 4 cited
- ResultsFound · 3 sources
- Reedley work historyFound · 1 source
Record references · 5 entries, each passage marked
Record references
5 entries behind this answer · newest first · as of 12 Nov 2026 09:40
08:31 · Reedley, from the clinical record (Simulated)
Reviewed and filed by K. AHMED 12 Nov 2026 08:31. U&E item closed · completed.
15:20 · Reedley (Simulated)
U&E received in the record: the test happened; designed to stay open until a clinician’s review of this result is recorded (the development build closes on receipt).
Northfield Pathology (fictional) · received 9 Nov 2026 15:20
U&E: Na 140 mmol/L, K 4.6 mmol/L, creatinine 131 µmol/L, eGFR 52 mL/min/1.73m² · no laboratory flag
Northfield Pathology (fictional) · received 3 Jun 2026 15:48
U&E: Na 140 mmol/L, K 4.7 mmol/L, creatinine 124 µmol/L, eGFR 56 mL/min/1.73m² · no laboratory flag
Northfield Pathology (fictional) · received 14 Nov 2025 16:05
U&E: Na 141 mmol/L, K 4.5 mmol/L, creatinine 119 µmol/L, eGFR 59 mL/min/1.73m² · no laboratory flag
In the development build · synthetic data, except steps marked Illustrative · Scripted reconstruction: the development build itself is not running on this page.
Open the full demonstration →Medication Reconciliation
Illustrative demonstration · intended workflow- Arrives
- A discharge or clinic letter
- Reedley prepares
- Its instructions beside the medication list, each difference marked
- The clinician decides
- You accept, amend, query or leave each line
The clinician decides every row. Reedley lines the letter up with the record and prepares drafts for the clinician to check.
Step 1 of 4 · Letter beside the record · Continues as you scroll
- Letter beside the record
- Differences in this letter
- Clinician reviews each row
- Handover summary
- Letter Amlodipine 5 mg tablets · One dailyRecord Amlodipine 10 mg tablets · One dailyDose change
- Letter Indapamide 2.5 mg tablets · StoppedRecord Indapamide 2.5 mg tablets · One each morningStopped
- Letter Omeprazole 20 mg dispersible gastro-resistant tablets · One each morningRecord Omeprazole 20 mg gastro-resistant capsules · One each morningFormulation change
- Letter Senna 7.5 mg tablets · Two at nightRecord Not on the medication recordNew
- Letter Atorvastatin 20 mg tablets · One at nightRecord Atorvastatin 20 mg tablets · One at nightContinuing
- Letter Levothyroxine 75 microgram tablets · One each morningRecord Levothyroxine 50 microgram tablets · One each morningStated two ways
- Letter Aspirin 75 mg dispersible tablets · One dailyRecord Aspirin 75 mg dispersible tablets · Stopped 6 Mar 2026Conflict
Step 1 · Letter beside the record
Each medicine in the letter is placed beside the matching entry on the medication record.
Step 2 · Differences in this letter
Each row is labelled with the difference found in this letter: new, stopped, dose change, formulation change, continuing, or unclear or conflicting. Other letters can differ in other ways.
Step 3 · Clinician reviews each row
The visitor reviews as Priya DESAI, clinical pharmacist (synthetic): Accept proposal, Amend, No change or Query on each row; on the two conflicting rows, Query, Amend or No change only.
Record change the letter asks for, for the prescriber to decide: change amlodipine on the medication record from 10 mg to 5 mg once daily, as the letter states in ¶2 and the medicines table.
- Accept proposalExample
- Amend
- No change
- Query
Example decision for Priya DESAI, clinical pharmacist (synthetic). In the full demonstration you decide every row.
Step 4 · Handover summary
A handover summary lists every decision with its reason and source. Nothing is written to the record.
Amlodipine: proposal accepted by Priya DESAI, clinical pharmacist (synthetic). Change from 10 mg to 5 mg once daily assigned to the prescriber.
The prescriber updates the record in the clinical system. Reedley has not changed the medication record.
Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.
Open the full demonstration →Complex Medication Changes
Illustrative demonstration · intended workflow- Arrives
- A specialist letter changing several medicines over weeks
- Reedley prepares
- Instructions, gaps and questions separated, and a clarification drafted
- The clinician decides
- A clinician confirms the plan before any dates or quantities
Step 1 of 4 · Gaps and conflicts flagged · Continues as you scroll
- Gaps and conflicts flagged
- Checks in five states
- Dated two-track schedule
- Draft quantities
Step 1 · Gaps and conflicts flagged
Synthetic letter, real medicine names · Liam HARTLEY · NHS 999 000 2010
Prescription directions cannot yet be finalised.
Conflict
Lamotrigine: the letter and the record differ
- The letter states lamotrigine 100 mg twice daily.The record has two lamotrigine repeat entries: 50 mg tablets, one twice daily, and 25 mg tablets, one twice daily.Clarification requiredReedley does not decide which dose is current.
- Derived · Reedley’s reconstruction from the record, not stated in itThe two entries together come to 75 mg twice daily, if both are taken at each dose; this differs from the letter.
Step 2 · Checks in five states
Synthetic letter, real medicine names · Liam HARTLEY
Prescription directions cannot yet be finalised.
3 need clarification · 2 need clinician review · 1 evidence found.
- Current lamotrigine doseClarification requiredUnresolved
- Valproate reductionClarification requiredUnresolved
- Lamotrigine increaseClarification requiredUnresolved
- Interactions not checkedClinician review requiredReviewed by Dr H. MARSH (synthetic) · 28 Oct 15:10
- ValproateClinician review requiredReviewed by Dr H. MARSH (synthetic) · 28 Oct 15:10
- Specialist follow-upEvidence found
Reviewed appears only after a named clinician records it; Unresolved only when no reply is found by the chase date.
Step 3 · Dated two-track schedule
A separate plan with fictional medicines · not a completed version of the letter
Confirmed plan · Medicine A and Medicine B on one dated axis
Medicine A10 mg once dailyChanges on this date
Medicine B300 mg twice dailyChanges on this date
Show as a table
| Track | From | To | Dose |
|---|---|---|---|
| Medicine A | 16 Nov 2026 | 22 Nov 2026 | 10 mg once daily |
| Medicine A | 23 Nov 2026 | 29 Nov 2026 | 10 mg twice daily |
| Medicine A | 30 Nov 2026 | 6 Dec 2026 | 20 mg twice daily |
| Medicine A | 7 Dec 2026 | 10 Jan 2027 | 40 mg twice daily |
| Medicine B | 16 Nov 2026 | 29 Nov 2026 | 300 mg twice daily |
| Medicine B | 30 Nov 2026 | 13 Dec 2026 | 200 mg twice daily |
| Medicine B | 14 Dec 2026 | 10 Jan 2027 | 150 mg twice daily |
| Review point | 23 Nov 2026 | 29 Nov 2026 | Practice review |
| Review point | 7 Dec 2026 | 13 Dec 2026 | Practice review |
| Review point | 4 Jan 2027 | 8 Jan 2027 | Test X |
| Review point | 11 Jan 2027 | 11 Jan 2027 | Specialist review |
Step 4 · Draft quantities
Fictional medicines · numbers chosen to show the arithmetic; not doses of any real medicine
Worked out by the demonstration’s deterministic calculator from the confirmed plan · Whole plan, 16 Nov 2026 to 10 Jan 2027 (56 days)
Medicine A 10 mg tablets
- Medicine
- Medicine A
- Strength
- 10 mg
- Form
- tablet
Take ONE tablet ONCE a day for 7 days (16 Nov 2026 to 22 Nov 2026)
Working 16 Nov 2026 to 22 Nov 2026: 7 days × 1 tablet × 1 dose a day = 7
Take ONE tablet TWICE a day for 7 days (23 Nov 2026 to 29 Nov 2026)
Working 23 Nov 2026 to 29 Nov 2026: 7 days × 1 tablet × 2 doses a day = 14
Take TWO tablets TWICE a day for 7 days (30 Nov 2026 to 6 Dec 2026)
Working 30 Nov 2026 to 6 Dec 2026: 7 days × 2 tablets × 2 doses a day = 28
None in this supply period.
Quantity49 tablets7 + 14 + 28 = 49
Illustrative demonstration · intended workflow · Scripted reconstruction: the development build itself is not running on this page.
Open the full demonstration →Medicines intelligence
Built around medicines.
Medication changes, shortages, requests and high-risk monitoring, laid out for the prescriber’s decision.
Medication Reconciliation
Illustrative demonstration · intended workflowArrivesA discharge or clinic letterReedley preparesIts instructions beside the medication list, each difference markedThe clinician decidesYou accept, amend, query or leave each lineSee the capabilityComplex Medication Changes
Illustrative demonstration · intended workflowArrivesA specialist letter changing several medicines over weeksReedley preparesInstructions, gaps and questions separated, and a clarification draftedThe clinician decidesA clinician confirms the plan before any dates or quantitiesSee the capabilityMedicines Shortages
Illustrative demonstration · intended workflowArrivesA medicine in short supplyReedley preparesThe product and patient factors that matter, side by sideThe clinician decidesThe prescriber choosesSee the capabilityPrescription Request Triage
In the development build · synthetic dataArrivesRepeat and one-off prescription requestsReedley preparesRequests grouped by what the record shows, each with a briefThe clinician decidesThe prescriber decides on every requestSee the capabilityResults, Monitoring and Recalls
Illustrative demonstration · intended workflowArrivesA medicine that needs blood testsReedley preparesEach result linked to its request and monitoring requirement; follow-up kept openThe clinician decidesA clinician reviews; follow-up is designed to close only when that review is recordedSee the capabilityShared Care and High-Risk Medicines
See the capability
Safety, governance and oversight
Clinicians decide. The evidence stays visible.
Six things a governance lead will ask about, each marked by where it stands today: a design commitment, work underway, or independently evidenced.
Human clinical review
Every proposal is designed to wait for a named clinician to accept, edit or reject it. In the development build the review rules are enforced in Reedley’s own screens and the reviewer’s name is not yet a signed-in identity; enforcing the rules in the engine underneath is work underway.
Clinical safetyStatus: work underway. Independently evidenced: not yet.
Evidence provenance
Each finding, answer line and proposal links to the passage, entry or rule it came from, and the linked passage is shown word for word. This exists in the development build on synthetic letters; how reliably it holds on real correspondence has not been measured.
Responsible AIStatus: work underway. Independently evidenced: not yet.
Audit trail
Who decided what, when and on which evidence is kept as an append-only history. In the development build it is held in development storage; a production store is planned and not built.
Safety and governanceStatus: work underway. Independently evidenced: not yet.
Security controls
Practice-level separation of patient data and role-based access are part of the design. In the development build they are enforced in Reedley’s screens only, there is no authenticated user, and no independent security test or certification has taken place.
SecurityStatus: design commitment. Independently evidenced: not yet.
Integration constraints
Reedley is designed to work alongside clinical systems such as EMIS Web and SystmOne, and not to write to the medication record. Integration is not established on current evidence: the build runs against a simulated clinical system, and no supplier route has been applied for.
IntegrationsStatus: design commitment. Independently evidenced: not yet.
Clinical safety assurance
An engineering draft of a DCB0129 hazard log exists. No Clinical Safety Officer has reviewed it, so it is not a safety case, and whether any part of Reedley is a medical device has not yet been assessed.
Assurance registerStatus: work underway. Independently evidenced: not yet.
Nothing here is independently evidenced yet: every item in the assurance register is in progress, not applicable, not yet assessed or planned. Nothing on this site indicates certification, compliance or endorsement by the NHS or any other body.
For your role
Your role, your workflows.
Choose your role to see the workflows that matter most to you.
- Reconcile a discharge letter line by lineMedication ReconciliationIllustrative demonstration · intended workflow
- Work through prescription requests with their contextPrescription RequestsIn the development build · synthetic data
- Prepare a medication review from one assembled briefMedication ReviewIllustrative demonstration · intended workflow
- Read a specialist letter as linked findings and proposed workDocument IntelligenceIn the development build · synthetic data
- Ask a question of the record and see the sourcesAsk ReedleyIn the development build · synthetic data
- See what is new since a chosen point or the last recorded reviewPatient ContextIn the development build · synthetic data
- One worklist with an owner and stage for every itemMy DayIn the development build · synthetic data
- Follow monitoring and recalls through to evidenceResults and MonitoringIllustrative demonstration · intended workflow
- Count open and closed work by kind and agePractice and PCN IntelligenceIllustrative demonstration · intended workflow
PCN leadership
Medicines work across practices, from each practice’s own work.
More for PCN leadership- High-risk medicine cohorts and what is duePopulation SurveillanceIllustrative demonstration · intended workflow
- Shared-care responsibilities and outstanding actionsShared CareIllustrative demonstration · intended workflow
- Open medicines work by practice, counted rather than rankedPractice and PCN IntelligenceIllustrative demonstration · intended workflow
Clinical governance
Every decision traceable to its evidence and its owner.
More for clinical governance teams- Review floors designed so practice settings cannot lower them (draft, unsigned)Safety and governance
- Provenance from each proposal to its source passageDocument IntelligenceIn the development build · synthetic data
- The audit trail of who decided what, and whenMy DayIn the development build · synthetic data
See it with your own work in mind.
Tell us your role and the workflows you care about, and we will walk you through them on synthetic data.